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Detection and Quantification of Glucuronidation of Ursolic Acid
(UA) in Human Liver Microsomes (HLMs).
Kamola Tolliboeva, Phillip M. Gerk; Department of Pharmaceutics

Abstract

Your Name, Your Mentor’s Name
Results

The purpose of this experiment was to establish and quantify the glucuronidation of ursolic
acid (UA) in human liver microsomes (HLMs). We used three (100, 10, 1 uM) different UA
concentrations incubated in 0.2 ug/uL HLMs for 1 hour. For each concentration of UA, we
had an experimental (with UDPGA) and control group (without UDPGA). Aqueous
samples were then treated with acetonitrile. Sample analysis was performed on a Cogent
bidentate C18 column, with 90% methanol and 10% aqueous 10 mM ammonium acetate,
and detection by electrospray mass spectrometry in negative ion mode ([M-H] = 455.3).
The results confirmed the disappearance of UA in the presence but not absence of UDPGA.

Discussions

The results of our experiment showed disappearance of UA after 1
hour in the samples of the experimental group containing UDPGA
compared to the control containing no UDPGA. This is consistent with
glucuronidation of UA in the incubation mixture.

Introduction
Ursolic acid (UA) is a lipophilic pentacyclic triterpenoid carboxylic acid that is widely
found in food, herbs, fruits, and some medicines such as diabetic medications[1,2,3]. It is
known to have range of biological activities such as serving as an antioxidant, antiinflammatory, and an antibacterial[3]. Current research on the properties of UA has shown
its potential for use in obesity, glucose intolerance, fatty liver disease[1], and tumor and
cancer prevention[3,4]. Clinical trials administering UA on human subjects are currently
underway, therefore, it’s important to understand the metabolic process or
glucuronidation of UA. Number of studies found the main UDP-glucuronosyltransferases
(UGT) involved in the glucuronidation of UA were UGT1A3 and UGT1A4[3]. Based on
the current research done on the metabolic mechanisms of UA, we hypothesize that UA
is glucuronidated by HLMs as a source of UGT enzymes.

With numerous research studies pointing at the benefits of UA, many researchers
are considering it as a potential therapeutic treatment for different diseases in
humans. However, interaction of UA with metabolizing enzymes and other
prescription drugs is largely unknown which creates several concerns regarding its
administration to patients in clinical trials. In this experiment we were able to
develop methods to establish the interaction of UA with UDPGA and UGT
enzymes found in HLMs. We quantified the interaction by the peak height
measured in uV indicating the disappearance of UA over time. Further refinement
of these methods will help us understand how UA interacts with different UGT
enzymes present in the human body (especially liver and intestine) allowing us to
maximize its oral bioavailability and efficacy.

1 uM UA 1 min control
1 uM UA 1 min experimental
1 uM UA 60 min control
1 uM UA 60 min experimental
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Figure 2: UA remaining after glucuronidation

Figure 1: Glucuronidation of UA

Additionally, we were able to quantify the glucuronidation of UA
based on its peak height which showed gradual decrease with time
indicating the loss of UA in the samples.

Methods

Table 1: Quantification of Glucuronidation of UA
Sample Name
Experimental and
control groups were set
up containing 3
different concentrations
(100, 10, 1 uM) of UA
in 50 mM Tris HCl (pH
7.4), 0.1mM
saccharolactone, 10 mM
MgCl2, 0.2 ug/uL
HLMs, 0.03125 mg/mL
alamethicin, and
distilled water.

The reactions were
initiated with an addition
of 2.5 mM UDPGA to
samples in experimental
group, and distilled water
in the control group and
incubated for 1 hour at
37oC. 50 uL samples from
3 concentrations of UA in
both groups were
collected at 1 and 60
minutes.

Each sample was treated
with of 200 uL of acetonitrile, vortexed, and
chilled on ice for 30
minutes, after which they
were centrifuged at
maximum speed (17000
RPM) and 4 oC for 10
minutes.

Supernatants were
transferred to HPLC vials
and analysis was
performed on a Cogent
bidentate C18 column,
with 90% methanol and
10% aqueous 10 mM
ammonium acetate, and
detection by electrospray
mass spectrometry in
negative ion mode ([M-H]
= 455.3).

Time (mins)

Height (uV)

1 uM experimental

1

262,035

1 uM control

1

262,214

1 uM experimental

60

165,437

1 uM control

60

230,565
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